Design, synthesis, and SAR of novel alpha-alkoxy-beta-arylpropionic acids as potent and balanced PPARalphagamma coagonists are described. One representative thereof, Aleglitazar ((S)-2Aa), was chosen for clinical development. Its X-ray structure in complex with both receptors as well as its high efficacy in animal models of T2D and dyslipidemia are also presented.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2009.03.036 | DOI Listing |
Publication Analysis
Top Keywords
potent balanced
8
aleglitazar potent
4
balanced dual
4
dual pparalpha/gamma
4
pparalpha/gamma agonist
4
agonist treatment
4
treatment type
4
type diabetes
4
diabetes design
4
design synthesis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!